HomeITCI • NASDAQ
add
Intra-Cellular Therapies Inc
Previous close
$76.69
Day range
$71.21 - $75.08
Year range
$45.50 - $84.89
Market cap
6.97B USD
Avg Volume
900.58K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 132.10M | 50.34% |
Operating expense | 104.72M | 10.66% |
Net income | -28.58M | 35.09% |
Net profit margin | -21.63 | 56.83% |
Earnings per share | -0.30 | 33.33% |
EBITDA | -33.96M | 28.15% |
Effective tax rate | -1.59% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 497.94M | -15.87% |
Total assets | 728.30M | -3.51% |
Total liabilities | 136.87M | 38.66% |
Total equity | 591.42M | — |
Shares outstanding | 96.81M | — |
Price to book | 12.49 | — |
Return on assets | -11.79% | — |
Return on capital | -13.90% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -28.58M | 35.09% |
Cash from operations | -2.06M | 94.74% |
Cash from investing | 47.42M | -5.65% |
Cash from financing | 3.00M | 37.36% |
Net change in cash | 48.36M | 264.83% |
Free cash flow | 53.67M | 316.31% |
About
Founded
2002
Website
Employees
610